Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan.
www.marketwatch.com
#Weightloss #drugs #covered #Medicare #Medicaid #experimental #program
Related Posts

Sony Group Corporation (SONY) Strengthens Core Segments Amid Mixed Entertainment Results
Sony Group Corporation (NYSE:SONY) is one of the best foreign stocks to buy right now. On February 9, Benchmark analyst…

Humana (HUM) Falls 21% on Medicare Payment Update
We recently published 10 Big Names With Painful Declines. Humana Inc. (NYSE:HUM) was one of the worst performers on Tuesday.…
Governments, multilateral lenders launch push for debt payment pauses
By David Latona and Karin Strohecker SEVILLE, Spain (Reuters) -A number of wealthy creditor nations and multilateral lenders have launched…

